Khattar Jack A., serving as Director and Officer, purchased 8,074 shares of SUPN at $25.30 each, amounting to a total trade value of $204,272.20. Given the current share price of $46.66 and significant positive returns over multiple time frames, this insider purchase is likely a bullish signal.
Company: Supernus Pharmaceuticals (SUPN)
Role: Director, Officer
Khattar Jack A. has shown a strong performance with recent trades significantly increasing in value. The latest trade on 2025-09-08 was purchased at $25.3 per share, and the current price is $46.66, yielding substantial returns.
There is no significant cluster activity noted at this time. However, recent trades by the CEO and CFO indicate a positive outlook for the company.
Average Return: 21.9%
Average Holding Time: 120 days
Consistent Profitability: Yes, trades were generally profitable.
Trade Size Comparison: The current trade size is typical compared to past trades.
Khattar Jack A.'s past trades have been consistently profitable, showing an average return of 21.9% with an average holding time of 120 days. The current trade size is consistent with previous transactions, suggesting a continuation of a successful trading strategy.
The insider trade by Khattar Jack A., a director and officer, suggests a moderate conviction level due to his dual leadership role. This open market purchase indicates genuine confidence, but the relatively small size of the purchase slightly tempers the signal strength. Additionally, the direct ownership implies a personal stake in the companyβs performance.
The insider trade reflects some confidence in the company due to the open market nature and direct ownership, but the small purchase size and lack of cluster activity result in a medium conviction score.
The insider trade by Khattar Jack A., who holds the role of Director and Officer at SUPN, is a bullish signal. His past trades have shown a strong performance, with a 365-day return of 37.88%, and this particular trade does not represent an outlier in size compared to his usual transactions. The timing of this purchase is noteworthy as it coincides with the stock trading near its all-time high, suggesting confidence in continued upward momentum. Given the substantial 60-day return of 40.8%, this trade is likely to precede a material upward move, reinforcing the positive outlook on the company's future performance.
A Director and Officer buying 8,074 shares at $25.30 on 2025-09-08 suggests a bullish stance, typically preceding momentum, and is worth watching for both short-term and mid-term entries given the 48.69% 180-day return.